Ignite Creation Date:
2026-03-26 @ 3:14 PM
Ignite Modification Date:
2026-03-27 @ 1:26 PM
Study NCT ID:
NCT07310095
Status:
RECRUITING
Last Update Posted:
2026-03-17
First Post:
2025-12-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's Disease (CD)
Sponsor:
Xian-Janssen Pharmaceutical Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-12-30
Start Date Type:
ACTUAL
Primary Completion Date:
2027-09-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-11-15
Completion Date Type:
ESTIMATED
First Submit Date:
2025-12-16
First Submit QC Date:
None
Study First Post Date:
2025-12-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-03-12
Last Update Post Date:
2026-03-17
Last Update Post Date Type:
ACTUAL